A clinical study showed that NLRP3 inflammasome activation exhibits a protective effect on the development of HCC, but other experimental data indicated that NLRP3 deficiency in HCC cells enhance surveillance of NK cells to delay the tumor development in the xenograft mice model (Wei et al., 2014; Lee et al., 2021). This evidence concerns the gene NLRP3 and hepatocellular carcinoma.